Licensing News
🇪🇺 EMAEMA breaking news and regulatory updates for BD, investors, and analysts
Showing 1–10 of 10 articles
EU Pharma Package exclusivity timelines: what innovators can do now
China Becomes Big Pharma's Essential R&D Partner
MFN Drug Pricing Reshapes International Life Sciences Licensing Deals
Owkin and AstraZeneca Enhance AI Collaboration for Drug Research
European Navenibart Deal: A Strategic Win for BioCryst's Rare Disease Portfolio
SERB Pharmaceuticals Acquires European and MENA Rights to Idefirix® (imlifidase) from Hansa Biopharma AB
BioCryst Secures $70M Upfront in European Licensing Deal for Navenibart Hereditary Angioedema Treatment
Pharma 2026: Key Takeaways from EU Biopharma & Medtech
Reuters Pharma EU: Funding & Dealmaking Key Takeaways
Pharma Partnering EU 2026: Biotech BD&L Trends to Watch